Veronika Rayzman

A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk

Magnus Larsson, Veronika Rayzman, Marc W. Nolte et al. · Science Translational Medicine · 2014 · 332 citations

Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory Arthritis

Ian K. Campbell, David Tai Leong, Kirsten M. Edwards et al. · The Journal of Immunology · 2016 · 81 citations

Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR

Con Panousis, Veronika Rayzman, Terrance G. Johns et al. · British Journal of Cancer · 2005 · 47 citations · Full text

Immunocytochemical Technique, Immunology, Immunotherapeutics +17

CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors

Con Panousis, Urmi Dhagat, Kirsten M. Edwards et al. · mAbs · 2015 · 42 citations · Full text

Inflammatory Lung Disease, Lung Inflammation, Immune Regulation +24

Development and Characterization of an Anti-FXIIa Monoclonal Antibody for the Treatment of Hereditary Angioedema

Zhihui Cao, Mark Biondo, Veronika Rayzman et al. · Journal of Allergy and Clinical Immunology · 2015 · 16 citations

Hereditary Angioedema, Immunology, Anti-fxiia Monoclonal Antibody +4